Biden-Harris’ Price-Fixing Scheme on Medicare Drug Costs Is a Prescription for Pain
‘We finally beat big pharma,’ president crows, but price controls always have unintended consequences
The White House is touting a deal with pharmaceutical companies to shave $6 billion off Medicare costs by 2026, a move they say will save $1.5 billion for seniors. The headlines will score political points, but a less sunny prognosis is taking shape: More pain tomorrow for promises of relief today.
Please check your email.
A verification code has been sent to
Didn't get a code? Click to resend.
Have an account? Log In
To continue reading, please select:
Limited Access
Enter your email to read for FREE
Get 1 FREE article
Continue with
or
Unlimited Access
Join the Sun for a PENNY A DAY
$0.01/day for 60 days
Cancel anytime
100% ad free experience
Unlimited article and commenting access
Full annual dues ($120) billed after 60 days
